L. P. Balant

2.2k total citations
51 papers, 1.7k citations indexed

About

L. P. Balant is a scholar working on Pharmacology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, L. P. Balant has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 16 papers in Psychiatry and Mental health and 15 papers in Pharmacology. Recurrent topics in L. P. Balant's work include Pharmacogenetics and Drug Metabolism (15 papers), Schizophrenia research and treatment (11 papers) and Treatment of Major Depression (11 papers). L. P. Balant is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Schizophrenia research and treatment (11 papers) and Treatment of Major Depression (11 papers). L. P. Balant collaborates with scholars based in Switzerland, United Kingdom and United States. L. P. Balant's co-authors include Marianne Gex‐Fabry, Androniki E. Balant-Gorgia, Pierre Dayer, A. E. Balant-Gorgia, J Fabré, G Garrone, P. L. Morselli, Leon Aarons, Jean‐Louis Steimer and Malcolm Rowland and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

L. P. Balant

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. P. Balant Switzerland 23 411 380 364 241 232 51 1.7k
John T. Callaghan United States 17 385 0.9× 879 2.3× 423 1.2× 328 1.4× 485 2.1× 42 2.1k
P. van Brummelen Netherlands 36 344 0.8× 410 1.1× 365 1.0× 692 2.9× 422 1.8× 136 3.9k
Kenneth S. Albert United States 26 261 0.6× 332 0.9× 561 1.5× 146 0.6× 178 0.8× 64 1.7k
Allen J. Sedman United States 32 357 0.9× 531 1.4× 661 1.8× 603 2.5× 513 2.2× 86 3.2k
L Balant Switzerland 26 116 0.3× 422 1.1× 370 1.0× 395 1.6× 176 0.8× 85 1.9k
Y. W. Francis Lam United States 21 555 1.4× 545 1.4× 332 0.9× 191 0.8× 300 1.3× 74 1.7k
Thorir D. Bjornsson United States 28 87 0.2× 666 1.8× 295 0.8× 466 1.9× 244 1.1× 72 2.8k
Samuel Vožeh Switzerland 18 157 0.4× 251 0.7× 403 1.1× 291 1.2× 300 1.3× 28 1.8k
Ziad Hussein United Kingdom 26 491 1.2× 201 0.5× 172 0.5× 229 1.0× 554 2.4× 99 1.9k
G. Bianchetti France 21 255 0.6× 184 0.5× 277 0.8× 163 0.7× 231 1.0× 78 1.5k

Countries citing papers authored by L. P. Balant

Since Specialization
Citations

This map shows the geographic impact of L. P. Balant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. P. Balant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. P. Balant more than expected).

Fields of papers citing papers by L. P. Balant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. P. Balant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. P. Balant. The network helps show where L. P. Balant may publish in the future.

Co-authorship network of co-authors of L. P. Balant

This figure shows the co-authorship network connecting the top 25 collaborators of L. P. Balant. A scholar is included among the top collaborators of L. P. Balant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. P. Balant. L. P. Balant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gex‐Fabry, Marianne, Androniki E. Balant-Gorgia, L. P. Balant, et al.. (2004). Time course of clinical response to venlafaxine: relevance of plasma level and chirality. European Journal of Clinical Pharmacology. 59(12). 883–891. 51 indexed citations
2.
Balant, L. P., et al.. (2000). Cultural differences: implications on drug therapy and global drug development. International Journal of Clinical Pharmacology and Therapeutics. 38(2). 47–52. 34 indexed citations
3.
Balant-Gorgia, Androniki E., et al.. (1999). Therapeutic Drug Monitoring of Risperidone Using a New, Rapid HPLC Method: Reappraisal of Interindividual Variability Factors. Therapeutic Drug Monitoring. 21(1). 105–115. 97 indexed citations
4.
Rowland, Mary M., L. P. Balant, Meindert Danhof, et al.. (1997). The Population Approach: Measuring and Managing Variability in Response, Concentration and Dose, Commission of the European Community, Luxembourg. Research Explorer (The University of Manchester). 4 indexed citations
5.
Gex‐Fabry, Marianne, Androniki E. Balant-Gorgia, & L. P. Balant. (1997). Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions. Therapeutic Drug Monitoring. 19(1). 1–10. 10 indexed citations
6.
Gravel, Patricia, Claude Walzer, Christiane Aubry, et al.. (1996). New Alterations of Serum Glycoproteins in Alcoholic and Cirrhotic Patients Revealed by High Resolution Two-Dimensional Gel Electrophoresis. Biochemical and Biophysical Research Communications. 220(1). 78–85. 64 indexed citations
7.
Aarons, Leon, Malcolm Rowland, L. P. Balant, et al.. (1996). Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. European Journal of Clinical Pharmacology. 49(4). 251–254. 44 indexed citations
8.
Vožeh, Samuel, Jean‐Louis Steimer, Malcolm Rowland, et al.. (1996). The Use of Population Pharmacokinetics in Drug Development. Clinical Pharmacokinetics. 30(2). 81–93. 96 indexed citations
9.
Meyer, Urs, R. Amrein, L. P. Balant, et al.. (1996). Antidepressants and drug‐metabolizing enzymes — expert group report. Acta Psychiatrica Scandinavica. 93(2). 71–79. 49 indexed citations
10.
Gex‐Fabry, Marianne, Androniki E. Balant-Gorgia, & L. P. Balant. (1995). Potential of Concentration Monitoring Data for a Short Half-Life Drug. Therapeutic Drug Monitoring. 17(1). 39–46. 21 indexed citations
11.
Gravel, Patricia, Jean‐Charles Sanchez, Claude Walzer, et al.. (1995). Human blood platelet protein map established by two‐dimensional polyacrylamide gel electrophoresis. Electrophoresis. 16(1). 1152–1159. 51 indexed citations
12.
13.
Balant-Gorgia, A. E., L. P. Balant, & A. Andréoli. (1993). Pharmacokinetic Optimisation of the Treatment of Psychosis. Clinical Pharmacokinetics. 25(3). 217–236. 19 indexed citations
14.
Balant-Gorgia, Androniki E., Marianne Gex‐Fabry, & L. P. Balant. (1991). Clinical Pharmacokinetics of Clomipramine. Clinical Pharmacokinetics. 20(6). 447–462. 91 indexed citations
15.
Balant, L. P. & Marianne Gex‐Fabry. (1990). Review Physiological pharmacokinetic modelling. Xenobiotica. 20(11). 1241–1257. 20 indexed citations
16.
Balant, L. P., Éric Doelker, & P Buri. (1990). Prodrugs for the improvement of drug absorption via different routes of administration. European Journal of Drug Metabolism and Pharmacokinetics. 15(2). 143–153. 22 indexed citations
17.
Wellman, Maria, et al.. (1990). Pharmacokinetics of dimetindene after intravenous and oral administration to healthy volunteers.. PubMed. 40(12). 1346–8. 4 indexed citations
18.
Balant-Gorgia, A. E., L. P. Balant, & G Garrone. (1989). High Blood Concentrations of Imipramine or Clomipramine and Therapeutic Failure. Therapeutic Drug Monitoring. 11(4). 415–420. 28 indexed citations
19.
Balant-Gorgia, A. E., et al.. (1987). Stereoselective disposition of flupentixol: influence on steady state plasma concentrations in schizophrenic patients. European Journal of Drug Metabolism and Pharmacokinetics. 12(2). 123–128. 6 indexed citations
20.
Balant-Gorgia, A. E., et al.. (1986). Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites. European Journal of Clinical Pharmacology. 31(4). 449–455. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John T. Callaghan Breakdown of academic impact, for papers by P. van Brummelen Breakdown of academic impact, for papers by Kenneth S. Albert Breakdown of academic impact, for papers by Allen J. Sedman Breakdown of academic impact, for papers by L Balant Breakdown of academic impact, for papers by Y. W. Francis Lam Breakdown of academic impact, for papers by Thorir D. Bjornsson Breakdown of academic impact, for papers by Samuel Vožeh Breakdown of academic impact, for papers by Ziad Hussein Breakdown of academic impact, for papers by G. Bianchetti
Rankless by CCL
2026